Mobai simplifies everyday life and increases ICT security by using biometrics to: Verify and authenticate people, Detect attacks on facial recognition systems, Detects Face Morph Images in ID photos, and Provide technology to use biometrics in digital signatures. A spin-off from the Norwegian Biometrics Laboratory at the Norwegian University of Science and Technology. We offer: Opportunity to work with products and services that are fundamental to secure everyone a part in a digital world regardless of age, nationality, language, ethnicity, IT literacy, and IT experience.To become a part of a dedicated, talented, and passionate team with international ambitions and international opportunities A job that offers lots of freedom and an equal amount of responsibility and accountability. Professional challenges, significant responsibility, and the opportunity to directly influence products that help shape the future of the biometric industry.Great opportunities for further learning and professional development in one of the fastest-growing areas in the tech industry - academically and professionally. Flexible office arrangements. Physical location, hybrid meeting places, and home office. Modern and central offices in Oslo and GjøvikCompetitive terms and benefits include insurance (health, travel, and pension)

Infraspace is a new cloud-based platform for early-stage infrastructure planning and design. Save time. Lower costs. Reduce environmental impact. We focus on the early stage planning and design of the projects. That's when changes have the biggest impact on costs, quality, and sustainability. Infraspace is a new platform to empower teams to make better decisions based on data and analyses. ✅Optimization algorithms ✅Cost and CO2 estimates ✅Environmental analyses

Monetor is an automated currency department for corporate market. The market segment is hugely under-serviced and Monetor will offer the similar services that a large corporate enjoys to small and medium sized companies.Non-transparent pricing and partially complex solutions of foreign exchange products coupled with marginal resources and competence are challenging factors for the SME market, when doing cross border business. Our offering is to gather and analyse vendor invoices, historical transactional information, FX rate feeds thereby providing the user with real-time Monitoring of currency exposure on an invoice by invoice basis. This information will be used to determine the to the customer cost regarding currency exposure and cross border payments. Monetor will execute spot payments and hedge future credits/debits, within the parameters of the firms’ pre-set policy or strategy for managing foreign exchange risk.  Our aim is to reduce the costs to the business and eliminate currency risk.

EpiGuard AS is an innovative Norwegian Medical Technology Company established in 2015 by a group of doctors at the Oslo University Hospital (OUS) together with co-founders Inven2, Eker Group AS, and Hansen Protection AS. EpiGuard has evolved into a highly skilled knowledge-based company. The business model is to develop and manufacture high-end medical equipment for the safe transport of contagious patients. The products will be distributed globally through strategic partners. Currently, the main product is the medical isolation and transportation system, EpiShuttle. The system is developed by clinical experts at OUS, with first-hand experience in providing advanced treatment and transportation of patients with highly infectious diseases, such as Ebola.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

A bio-and medtech Company developing and selling proprietary solutions for using oxygen in various applications. Currently focussing on beverages (water, sports- and isotonic drinks), wound healing, cosmetics and fish farming. Licensing platform technology for applying oxygent to other products. Oxy Solutions is a privately held Norwegian based biotech company that has developed and patented an innovative technology for highly oxygenating liquid. Oxy Solutions'​ core business and strategy is to develop, document, IP protect, and commercialize the technology primarily within wound healing. The company has an in-house R&D facility in Norway. The company has funding from the Norwegian Research Council. Oxy Solutions is in possession of patented technology that makes it possible to greatly increase the dissolved level of oxygen in water. Tests have indicated stable levels in excess of 70 mg/l, or approximately 10 times higher than previously thought possible.

CYBERSECURITY FOR INDUSTRIAL NETWORKS AND CONTROL SYSTEMS Secure-NOK® is a technology company providing cybersecurity solutions for monitoring industrial networks (OT), and for detecting vulnerable areas. The company has vast experience and recognized technology, and has participated in several research projects with outstanding results. The technology (SNOK) can detect any abnormal event in a network and prevent important infrastructure from experiencing downtime due to malicious attack. Today, most industries are digitized, and thus more exposed to attacks from the outside. With technology from Secure-NOK, such attacks will be detected early, and thus avoid damage and downtime. Secure-NOK has developed patented sensors which are installed in a OT network, and which capture and report any abnormal traffic. The company has sensors for both networks, end-stations and PLC systems.

AnsuR solves globally applicable challenges related to photo and video communication in mobile radio and satellite networks. Visual data constitutes over 70% of all Internet traffic, and as sensor resolution increases, the need for communication bandwidth increases correspondingly. The AnsuR software system RAIDO can reduce the bandwidth requirements by 99% via unique solutions to the fundamental challenges. Advanced Computer vision solutions with deep learning at being developed. RAIDO is also a Big Data communication solution, suitable for large sensor populations and the Internet of Things (IoT). RAIDO is certified for use in mobile satellite systems, where the challenges are particularly challenging, but everyone has also experienced bad mobile cell phone coverage. AnsuR makes critical information available to remote users. In drones and autonomous aerial vehicles and surface vessels, the ability to communicate camera content independently of the terrestrial infrastructure is key. RAIDO can also solve problems with large emails and documents due to images and graphics and provide Super-light Interactive Documents, showing the ability to transform how we communicate visual data. AnsuR has based its first years since the start of operations in 2006 on research and innovation, has currently sold the key products to representative customers for list price, and is ready to ramp up activities, marketing, and sales efforts. Both technology and market are proven. AnsuR has about 15 employees in hi-tech software engineering, located in Oslo and Barcelona. The company is currently self-funded and has not yet taken any investments. The shareholders are basically the founders and the employees.

Globus.ai is cloud based, human centric software that enables staffing agencies and recruiters to place more candidates – faster. Much faster. From requests to search, matching and booking – the whole process can take seconds. Even with high volume job requirements. Our customers typically improve their results (net fee income) with 40%. Globus.ai has developed a unique and intelligent software that enables staffing agencies and recruiters to find and place people with relevant skills and competencies– perfectly matching the needs of their clients. Thanks to human centric artificial intelligence, even the incoming orders are handled automatically, but still in a personal way. Then - the placing of competencies and interests with matching roles, is done within minutes. Due to machine learning, this intelligent process will speed up over time, and replace hours and minutes with seconds. Globus.ai can both speed up and transform you as a professional - and boost your recruiting business.

Waved is developing solutions to help restaurants, bars, hotels, and retail create a better atmosphere for their guests. Happy guests stay longer and spend more. By using IoT sensors to analyze the human-made noise, Waved automatically adjusts the music volume to a perfect level - no matter the circumstances. We make the restaurant and hospitality experience better, no more shouting to hold a conversation - the background music will always balanced. WHY WAVED? THE CUSTOMER EXPERIENCE The goal of restaurants, bars and other eating and drinking venues is to provide the best customer experience possible. The customer’s well-being is directly linked to the amount of money spent during their stay and the likelihood that they will return. THE IMPORTANCE OF SOUND Research has shown that a well composed sound environment has direct impact on how the guest’s overall experience and even how the taste of the food and drinks are perceived. LARGE INVESTMENTS IN SOUND EQUIPMENT Most restaurants and bars know how important the sound environment is for a good customer experience and it is common to spend thousands of dollars on sound equipment. WHAT DECIDES THE VOLUME? The volume is usually controlled manually by waiters or bartenders in-between their other duties. Lack of information and knowledge of the customers perception often lead to poor volume level decisions. THE SOLUTION IS WAVED Wall-mounted sensors are placed around the venue and listens to the sound environment. Waved’s brain is build around our self-developed algorithm. It has the ability to understand and evaluate the sound environment and is used to set the perfect sound volume in order to maximise the customer experience.

The Pitch SignLab helps families that need to learn sign language or sign-assisted communication to communicate The What Parents to children who are severely hard of hearing or deaf need to learn sign language to communicate. Today, only 1 in 4 parents to deaf children in high-income countries manage to learn sign language. In low-income countries, it is believed to be less than 1 in 10. Families with individuals that benefit from sign-assisted communication face the same challenge. These include the parents to children with Down Syndrome, severe autism or Cerebral palsy. The How An international learning platform for sign languages and sign-assisted communication. The SignLab learning platform is fully digital and can incorporate new languages within weeks. The user only needs access to a smartphone or a computer. The platform makes it fun and easy to learn through gamification and timed encouragement. To ensure that the user gets the most out of every learning session, our review functionality incorporates an AI that knows what signs you are about to forget. The AI then designs a learning session that is tailored to the individual user’s need. Our curriculum is designed in cooperation with sign language teachers in each language. The platform launched in open beta in Norway November 2018. Feedback from parents and sign language teachers gave it a NPS of +64. The platform saw exponential growth with an average growth rate of 276% each month for the first three months (Nov-Feb). This growth all came from word of mouth, $0 spent on marketing. The Why Today less than 10% of the 64 million parents to deaf and hard of hearing children know sign language due to the low availability of education centers. Exclusion from communication have a significant impact on everyday life, causing feelings of loneliness, isolation, and frustration. The inability to properly communicate have a significantly adverse effect on the academic performance of children. SignLab works towards a society where all families have access to teaching themself, their children and their community signs and sign language so that everyone can feel included.

Taking the GPS revolution indoors combining standard Bluetooth and audioOur patented method of combining industry standard Bluetooth (BLE) and audio has enabled us to bring the GPS revolution indoors. Our SDK is compatible with the billions of existing iOS and Android devices. We take advantage of the unique properties of ultrasound for accurately measuring distances. When combined with our novel signal processing algorithms we achieve accuracy unrivaled by other indoor positioning technologies.

Oslo-based Epigram specialises in computer vision and visual classification, developing cutting edge tools and software to collect and analyse big data, with an acute focus on the application of AI to understand content. The company, founded in 2017, worked with multiple clients, including Huddly, Gjensidige, Tradono, and No Isolation to develop bespoke artificial intelligence and machine learning solutions.

Smartwatt er et software selskap som benytter AI og skyteknologi til å optimalisere styringen og senke energiforbruket i næringsbygg. Vår teknologi identifiserer hvor og hvordan næringsbygg kan optimalisere eksisterende installasjoner for å spare maksimalt med strøm. Smartwatts software benytter maskinlæringsalgoritmer, inneklimadata, værmelding og morgendagens strømpriser til å regne ut optimale driftsparametre for næringsbygg som utveksles automatisk med byggets eksisterende styringssystem. Løsningen installeres raskt i bygget og kundene våre opplever resultater på svært kort tid. Av de 70 bygg som allerede har tatt teknologien i bruk er effekten betydelig og har ført til en besparelse på opptil 30%. Vi er fortsatt i startfasen av vår reise, men har allerede etablert oss som en seriøs aktør og utfordrer i bransjen. Asko, Elkjøp, Elektroimportøren, BI og Møller Bil, er blant kundene som har tatt i bruk Smartwatt sine løsninger, og vi har store ambisjoner. Med sterke investorer i ryggen gjennom en nylig gjennomført finansieringsrunde, ledet av Hafslund Invest og DNV, er vi klare til å fortsette veksten og la flere bedrifter dra nytte av våres løsninger. Smartwatt sitt mål er å bli markedsledende i Norge samtidig som vi vil fortsette å skalere opp i Norden

Age Labs is a Norwegian molecular diagnostics company that discovers, develops and commercializes biomarkers for the early detection of age-related diseases. We offer a service for evaluating epigenetic drug effects for use in clinical trials. Our biomarker discovery pipeline includes a biological age predictor and a test predicting the severity of COVID-19 infection. To date, we have raised 30 MNOK in private and public funding, and became a Nordic Startup Awards finalist in 2020. We are supported by strong commercial and R&D partners, including Oslo University Hospital, the Norwegian Institute of Public Health, Merck Group and Fürst Medical Laboratory. Our mission is to develop novel precision biomarkers for the early detection of age related diseases to extend the human healthspan.